Please find attached Capital Change Notice regarding the issue of ordinary shares.
This notice relates to CBD's recent announcement confirming its
acquisition of the outstanding 40% shareholding in Midwest Pharmaceutics NZ Limited (Midwest).
A new pricing regime comes as the company seeks amendments to loan covenants.
Herbert unimpressed by Vital's refusal for due diligence and failure to meet guidance.
The business is reportedly being hit hard by increasing air freight industry competition.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details